secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invivyd, Inc. (IVVD)
CIK:        0001832038
Form:       8-K
Filed at:   2022-03-01T23:59:59+00:00
Accession:  0001193125-22-061608
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Adagio CMO Lynn Connolly resigns; Hershberger takes over clinical development
-----------------------------------------------------------------------------

- CMO Lynn Connolly resigns effective March 25, 2022, to tend to family obligations.
- Connolly remains through ADG20 Phase 2/3 data analysis and transition of duties.
- Chief Development Officer Ellie Hershberger permanently assumes responsibility for clinical development programs.
- Company expects to enter into a consulting agreement with Dr. Connolly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832038/000119312522061608/0001193125-22-061608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832038/000119312522061608/d656486d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-061608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer